ZDHHC9 and breast carcinoma: Different from the studies conducted on breast cancer, colorectal cancer, and lung adenocarcinoma, this study found that, in the pancreatic tumor xenograft model, tumors with ZDHHC9 knockdown led to a change in PD-L1 level on the surrounding immune cells.